Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | SPR | P35270 | 2/20 | 0.44 |
| ▸ | USP30 | Q70CQ3 | 3/20 | 0.43 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.43 |
| ▸ | RORC | P51449 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | HPGDS | O60760 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27143853 | 0.92 | KDM4E (0.50) | KDM4EPKMSPRUSP30GPR119 | |
| Hydrochloric Acid SCHEMBL30020380 | 0.86 | KDM4E (0.47) | KDM4EPKMSPRUSP30GPR119 | |
| SCHEMBL400513 | 0.78 | NR1H2 (0.50) | KDM4EMEN1KMT2A | |
| SCHEMBL22169156 | 0.78 | NR1H2 (0.50) | KDM4EMEN1KMT2A | |
| SCHEMBL608991 | 0.78 | NR1H2 (0.50) | KDM4EMEN1KMT2A | |
| SCHEMBL24884312 | 0.78 | NR1H2 (0.50) | KDM4EMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL7149386 | 0.77 | NR1H2 (0.49) | KDM4EMEN1KMT2A | |
| SCHEMBL27340900 | 0.76 | HSD17B10 (0.55) | MEN1KMT2A | |
| SCHEMBL31132497 | 0.76 | GPR119 (0.51) | KDM4ESPRUSP30GPR119MEN1 | |
| SCHEMBL30998629 | 0.75 | RORC (0.42) | KDM4EPKMUSP30GPR119RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4326724-A1 | COMPOUND AS ADENOSINE A2A RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Chong Kun Dang Pharmaceutical Corp. (KR) | 2024-02-28 | — | — | EP | disclosed |
| WO-2022224180-A1 | COMPOUND AS ADENOSINE A2A RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2022-10-27 | — | — | WO | disclosed |